Public Market

IPO

Infinion Biopharma files draft papers with Sebi for IPO

Economic Times  

Infinion Biopharma has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial share sale. The initial public offering (IPO) comprises the sale of 45 lakh equity shares of Infinion Biopharma. The company may consider a pre-IPO placement of up to 7 lakh equity shares. Aryaman Financial Services is the sole book-running lead manager to the issue. Proceeds from the IPO will be used towards investment in Mobius Biomedical Inc, acquisition of licenses for product development of skincare and women's health products and working capital requirements. In addition, funds will be used for sales, marketing and distribution expenses for expanding the company's geographical reach and for general corporate purposes